
ARK Invest|7月 10, 2025 13:57
Can AI cut drug development costs from 2.4B to 600M and timelines from 13 to 8 years? Insilico Medicine CEO Alex Zhavoronkov shares how they’re using generative platforms to build a new biotech model and chase longevity. Watch FYI now!